TrialInternational journal of clinical oncology2018

A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy.

Takako Yanai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.